Page 106 - ITPS-7-4
P. 106

INNOSC Theranostics and
            Pharmacological Sciences                                Atropine-induced psychosis in organophosphate poisoning



            poisoning compared to other OP insecticides, with a case   monitoring and individualized treatment approaches.
            fatality rate of 6.5%.  Notably, while most patients presented   Understanding adverse drug reactions, pathophysiological
                           1
            fully alert, a minority exhibited impaired consciousness.    mechanisms, and pre-disposing factors are critical in
                                                          1
            This variability in clinical presentation underscores the   managing  this  complex  clinical  condition.  Continued
            need for individualized treatment approaches based on the   research efforts are warranted to further elucidate its
            severity of poisoning.                             underlying mechanisms and optimize treatment outcomes,
              Atropine’s potent pharmacological effects make   ultimately improving patient care and safety.
            it widely used in the management of OP poisoning.   Acknowledgments
            However, adverse effects, including psychosis, can occur,
            necessitating prompt recognition and intervention. The   None.
            diagnosis  of  atropine-induced psychosis aligns with the
            DSM-IV-TR criteria, with patients often meeting at least   Funding
            three of the four criteria for drug-induced psychosis.    None.
                                                          2
            Management strategies involve discontinuing the causative
            agent, adjusting the dose, and providing symptomatic   Conflict of interest
            treatment.
                                                               Dr.  Mohammed Misbah Ul Haq is an Editorial Board
              In cases of atropine-induced psychosis, discontinuation   Member of this journal, but was not in any way involved
            of atropine and substitution with alternative muscarinic   in the editorial and peer-review process conducted for
            agents such as physostigmine, glycopyrrolate, or   this paper, directly or indirectly. Separately, other authors
            scopolamine have  been effective  in alleviating  psychotic   declared that they have no known competing financial
                    3
            symptoms.  In addition, antipsychotics, such as    interests or personal relationships that could have
            haloperidol and benzodiazepines, such as diazepam or   influenced the work reported in this paper.
            lorazepam, are viable treatment options.  It is crucial to
                                             3
            note that adverse drug reactions can occur with atropine   Author contributions
            therapy,  particularly when  administered  intravenously,   Conceptualization: All authors
            emphasizing the importance of vigilant dose management   Formal analysis: All authors
            and early cessation of the offending drug to prevent further   Investigation: All authors
            complications. 4                                   Writing-original draft: All authors

              Recent advancements in understanding atropine-   Writing-review and editing: All authors
            induced psychosis have elucidated its pathophysiological
            mechanisms and pre-disposing factors. Hypotheses   Ethics approval and consent to participate
            regarding the underlying mechanisms include disruption   This case report is exempt from institutional review. Per
            of central cholinergic  neurotransmission,  altered   our institutional guidelines, case reports of three or fewer
            dopaminergic signaling, and modulation of glutamatergic   patients do not require institutional review board approval.
                                  5
            and GABAergic pathways.  Pre-disposing factors such   Verbal consent was obtained from the patient.
            as advanced age, pre-existing psychiatric disorders,
            substance abuse, polypharmacy, and underlying medical   Consent for publication
            comorbidities increase susceptibility to atropine-
            induced psychosis.  Moreover, the concomitant use   Verbal consent to publish his data was obtained from the
                            4
            of other medications with anticholinergic properties,   patient.
            such as antipsychotics, antidepressants, antihistamines,   Availability of data
            and antiparkinsonian agents, may potentiate the risk of
            psychosis.  Close monitoring and comprehensive clinical   The datasets used and/or analyzed during the current
                    6
            assessment are essential for accurate diagnosis and timely   study are available from the corresponding author upon
            intervention.                                      reasonable request.
            4. Conclusion                                      References

            Atropine-induced psychosis remains a rare but potentially   1.   Eddleston M, Buckley NA, Eyer P, Dawson AH. Management
            serious complication in the management of OP poisoning.   of  acute  organophosphorus  pesticide  poisoning.  Lancet.
            Recent case studies provide insights into its occurrence and   2008;371(9612):597-607.
            management strategies, emphasizing the need for vigilant      doi: 10.1016/S0140-6736(07)61202-1


            Volume 7 Issue 4 (2024)                         4                                doi: 10.36922/itps.4607
   101   102   103   104   105   106   107   108   109   110